Oncolytics Biotech Inc
TSX:ONC
Oncolytics Biotech Inc
Cash from Financing Activities
Oncolytics Biotech Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Oncolytics Biotech Inc
TSX:ONC
|
Cash from Financing Activities
CA$32m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
1%
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Financing Activities
$81.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Financing Activities
$842k
|
CAGR 3-Years
-85%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Financing Activities
$142m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Financing Activities
-$21.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Financing Activities
CA$5.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
See Also
What is Oncolytics Biotech Inc's Cash from Financing Activities?
Cash from Financing Activities
32m
CAD
Based on the financial report for Dec 31, 2023, Oncolytics Biotech Inc's Cash from Financing Activities amounts to 32m CAD.
What is Oncolytics Biotech Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
1%
Over the last year, the Cash from Financing Activities growth was 162%. The average annual Cash from Financing Activities growth rates for Oncolytics Biotech Inc have been -7% over the past three years , 19% over the past five years , and 1% over the past ten years .